Neurology Central

BET inhibitors could result in better survival for aggressive pediatric brain tumor patients

A team from Northwestern University (IL, USA) has reported that a molecule is capable of halting the growth of diffuse intrinsic pontine glioma (DIPG), a highly aggressive brainstem tumor.
To view restricted content, please:

1 Comment

  1. Is there a pediatric clinical trial upcoming in 2017 that will test this combination on DIPG patients?

Leave A Comment